BSE: APLLTD - Alembic Pharmaceuticals Limited

Altı ay boyunca karlılık: -8.66%
Temettü getirisi: +0.87%

Promosyon programı Alembic Pharmaceuticals Limited

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products.

daha fazla ayrıntı
The company was founded in 1907 and is headquartered in Vadodara, India.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

ISIN INE901L01018
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.8659
Дивиденд ао 11
Сайт https://alembicpharmaceuticals.com
Цена ао 1003.05
Günlük fiyat değişimi: -1.3% (1003.05)
Haftalık fiyat değişimi: -9.26% (1091.05)
Aylık fiyat değişimi: -6.72% (1061.35)
3 ayda fiyat değişimi: -13.89% (1149.65)
Altı ayda fiyat değişimi: -8.66% (1083.9)
Yıllık fiyat değişimi: +5.05% (942.45)
3 yılda fiyat değişimi: +20.66% (820.5)
5 yılda fiyat değişimi: +78.41% (554.9)
Yılbaşından bu yana fiyat değişimi: -10.31% (1103.75)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 2.49 6
P/BV 3.16 5
P/E 24.69 6
EV/EBITDA 17.77 6
Toplam: 6.5

Yeterlik

İsim Anlam Seviye
ROA, % 9.55 3
ROE, % 12.78 4
Toplam: 2.5

Temettüler

İsim Anlam Seviye
Div yield, % 0.8659 2.18
DSI 0.8571 8.57
Toplam: 4.14

Görev

İsim Anlam Seviye
Debt/EBITDA 1.06 8
Toplam: 9.2

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 32.71 5
karlılık Ebitda, % -41.82 0
karlılık EPS, % -18.89 0
Toplam: 1
Daha fazla ayrıntı

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
iShares MSCI India Small-Cap ETF 0.15813 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.07481 5.46 3.03583
iShares MSCI Emerging Markets Small-Cap ETF 0.05587 7.67 2.7853
WisdomTree India Earnings Fund 0.04848 5.23 1.65591
WisdomTree Emerging Markets SmallCap Dividend Fund 0.04404 1.35 5.00999
Vanguard FTSE All-World ex-US Small-Cap ETF 0.02 9.39 3.09932
Dimensional Emerging Markets Value ETF 0.01002 17.07 4.19508
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.00961 12.46 3.59676
Dimensional Emerging Markets Core Equity 2 ETF 0.00845 15.96 3.34087
Avantis Emerging Markets Equity ETF 0.00806 8.77 3.60513
Dimensional World ex U.S. Core Equity 2 ETF 0.00439 13.06 3.62488
SPDR Portfolio Emerging Markets ETF 0.00394 11.59 3.1879
Vanguard ESG International Stock ETF 0 6.39 3.07501

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Pranav Chirayu Amin Managing Director 122.2M 1975 (50 yıllar)
Mr. Shaunak Chirayu Amin MD & Executive Director 122.2M 1978 (47 yıllar)
Mr. Vinod Kamath President of Operations N/A
Dr. J. Venkat Raman M. S., Ph.D. Chief Scientific Officer N/A 1958 (67 yıllar)
Ms. Manisha Saraf Company Secretary & Compliance Officer N/A
Mr. Udit C. Amin Chief Business Development Officer N/A 1980 (45 yıllar)
Mr. Gautam Chatterjee Senior Vice President N/A 1961 (64 yıl)
Mr. Chirayu Ramanbhai Amin Executive Chairman & CEO 88M 1946 (79 yıllar)
Mr. Raj Kumar Shreeram Baheti B.Com.(Hon.), FCA, FCS Director of Finance, CFO & Executive Director 1959 (66 yıllar)
Mr. Ajay Kumar Desai Senior Vice President of Finance

Adres: India, Vadodara, Alembic Road - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://alembicpharmaceuticals.com